findmyKOL

Arshia Noori, MD

Basic profile

Cedars-Sinai Smidt Heart Institute

ORCIDNone on fileNPI
RegionLos Angeles, CA · WestSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Arshia Noori is a Cardiology physician affiliated with Cedars-Sinai Smidt Heart Institute. OpenAlex indexes 8 publications with 204 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
8publications

Distinct works indexed by OpenAlex.

204citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
39companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

8631 W 3rd St
Suite 610e
Los Angeles, CA 900485901

Telephone

310-746-5335

Provider last certified this registry record 28 Nov 2022.

View the NPPES registry record

Industry payments

39 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    74.2%
    Statin16.4%
    Atorvastatin Calcium62%Rosuvastatin Calcium32%Livalo4%Pravastatin Sodium2%
    Part D<11 patients
    Beta blocker15%
    Metoprolol Succinate57%Carvedilol22%Nebivolol Hcl11%Metoprolol Tartrate5%Propranolol Hcl Er3%Atenolol2%
    Part D<11 patients

    + 15 more classes in this area

  • Blood & clotting

    12.3%
    Factor Xa inhibitor9.7%
    Eliquis91%Xarelto9%
    Part D<11 patients
    P2Y12 inhibitor1.4%
    Clopidogrel78%Brilinta22%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    10.8%
    SGLT2 inhibitor6.3%
    Farxiga62%Jardiance21%Dapagliflozin10%Inpefa8%
    Part D<11 patients
    GLP-1 receptor agonist2.2%
    Ozempic76%Mounjaro24%
    Part D<11 patients

    + 4 more classes in this area

Where care is delivered (Part B)19% facility · 81% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”